The University of Santo Tomas Hospital is a hospital located at the University of Santo Tomas. The hospital has two divisions, a clinical teaching hospital that offers inexpensive medical care for ...

During the past decade, University of Santo Tomas Hospital conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 10 clinical trials were completed, i.e. on average, 142.9% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Santo Tomas Hospital" #1 sponsor was "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 5 trials, followed by "Otsuka Pharmaceutical, Inc., Philippines" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Swiss Federal Institute of Technology" with 2 trials sponsored and "Arcus Biosciences, Inc." with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Santo Tomas Hospital" #1 collaborator was "St. Luke's Medical Center" with 2 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator, "Glenmark Pharmaceuticals S.A." with 1 trials as a collaborator and "Global Alliance for Improved Nutrition" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "University of Santo Tomas Hospital" are "Epilepsy, Partial Seizures" (2 trials), "Rheumatoid Arthritis" (2 trials), "Systemic Lupus Erythematosus" (2 trials), "Arthritis, Juvenile Rheumatoid" (1 trials) and "Arthritis, Rheumatoid" (1 trials). Many other conditions were trialed in "University of Santo Tomas Hospital" in a lesser frequency.

Most popular intervention types in "University of Santo Tomas Hospital" are "Drug" (20 trials), "Device" (1 trials), "Dietary Supplement" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Cilostazol" (2 trials), "Pregabalin Dose Level 1" (2 trials), "Pregabalin Dose Level 2" (2 trials) and "BOS161721" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Santo Tomas Hospital" are 22 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "University of Santo Tomas Hospital". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in University of Santo Tomas Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of Santo Tomas Hospital, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 1 trials that are defined as “Not Applicable".

University of Santo Tomas Hospital has several departments that took part in Clinical trials: "Joint and Bone Center, University of Santo Tomas Hospital" - 2 trials